STOCK TITAN

Rallybio to Present at the 2024 Jones Healthcare Seaside Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Rallybio (Nasdaq: RLYB), a clinical-stage biotechnology company focusing on rare diseases, announced that its Chief Financial Officer, Jonathan Lieber, will present at the 2024 Jones Healthcare Seaside Summit. The presentation is scheduled for July 15, 2024, at 8:00 a.m. PT (11:00 a.m. ET) in Encinitas, CA.

A live webcast of the presentation will be available on Rallybio's website, with an archived replay accessible for 30 days after the event.

Positive
  • None.
Negative
  • None.

NEW HAVEN, Conn.--(BUSINESS WIRE)-- Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced that Jonathan Lieber, Chief Financial Officer of Rallybio, will present a corporate overview at the 2024 Jones Healthcare Seaside Summit on July 15, 2024 at 8:00 a.m. PT (11:00 a.m. ET) in Encinitas, CA.

A live webcast of the presentation will be accessible through the Events and Presentations section of Rallybio’s website at www.rallybio.com. An archived replay of the webcast will be available for 30 days following the presentation.

About Rallybio

Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a broad pipeline of promising product candidates aimed at addressing diseases with unmet medical need in areas of maternal fetal health, complement dysregulation, hematology, and metabolic disorders. The Company has two clinical stage programs: RLYB212, an anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and RLYB116, an inhibitor of complement component 5 (C5), with the potential to treat several diseases of complement dysregulation, as well as additional programs in preclinical development. Rallybio is headquartered in New Haven, Connecticut. For more information, please visit www.rallybio.com and follow us on LinkedIn and Twitter.

Investors

Samantha Tracy

Rallybio Corporation

(475) 47-RALLY (Ext. 282)

investors@rallybio.com

Kevin Lui

Precision AQ

(212) 698-8691

Kevin.Lui@precisionaq.com

Media

Victoria Reynolds

Mission North

(760) 579-2134

rallybio@missionnorth.com

Source: Rallybio Corporation

FAQ

When will Rallybio present at the 2024 Jones Healthcare Seaside Summit?

Rallybio will present at the 2024 Jones Healthcare Seaside Summit on July 15, 2024, at 8:00 a.m. PT (11:00 a.m. ET).

Who will present on behalf of Rallybio at the 2024 Jones Healthcare Seaside Summit?

Jonathan Lieber, the Chief Financial Officer of Rallybio, will present at the 2024 Jones Healthcare Seaside Summit.

Where is the 2024 Jones Healthcare Seaside Summit taking place?

The 2024 Jones Healthcare Seaside Summit will take place in Encinitas, CA.

How can I watch the Rallybio presentation at the 2024 Jones Healthcare Seaside Summit?

You can watch a live webcast of Rallybio's presentation on the Events and Presentations section of Rallybio's website. An archived replay will be available for 30 days after the event.

What is the stock symbol for Rallybio?

The stock symbol for Rallybio is RLYB.

Rallybio Corporation

NASDAQ:RLYB

RLYB Rankings

RLYB Latest News

RLYB Stock Data

41.08M
41.49M
4.06%
76.95%
1.29%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NEW HAVEN